News
SAN FRANCISCO, Apr. 4, 2019 (FORBESBOOKS RADIO) -Dave Messina is COO of Cofactor Genomics; their multidimensional biomarker tools use RNA to enable doctors, drug developers and researchers to [...]
SAN FRANCISCO, Apr. 2, 2019 (CLINICAL OMICS) – Jarret Glasscock is the founder and CEO of Cofactor Genomics, a diagnostics company leveraging the power of RNA and Predictive Immune Modeling [...]
SAN FRANCISCO, Apr. 2, 2019 (CLINICAL OMICS) – In 2013, much of the world was introduced to the burgeoning field of precision medicine when world-famous actress, Angelina Jolie, announced [...]
Cofactor Genomics to Present on Predictive Immune Modeling at 2019 American Association for Cancer Research Annual Meeting — Presenting early data in collaboration with TriStar Technology [...]
Awards Scientists and Clinicians Who Create Predictive Immune Models and Multidimensional Biomarkers Using the Cofactor ImmunoPrismTM Assay NEW YORK (BusinessWire), February 6, 2019 [...]
SAN FRANCISCO, Feb. 4, 2019 (FIERCE PHARMA) – Advances in new immunotherapies and novel combinations of therapies have resulted in an explosion of oncology clinical trials. While many of [...]
SAN FRANCISCO, Jan. 30, 2019 (STAT NEWS) – When your oncology drug is finally ready to move into clinical trials, it feels like you’ve made it to the Super Bowl. These are the big leagues; [...]
SAN FRANCISCO, Dec. 21, 2018 (TRAPELO) – In oncology today, diagnostic technology tools are key to helping scientists unlock the potential of precision medicine, so we were thrilled [...]
SAN FRANCISCO, Dec. 4, 2018 (BUSINESS WIRE) – Cofactor Genomics, a clinical RNA sequencing and translational assay developer, today announced a pilot study to evaluate use of Cofactor’s [...]
SAN FRANCISCO, Apr. 4, 2019 (GENETIC ENGINEERING & BIOTECHNOLOGY NEWS) – At the Clinical Biomarkers and World CDx Conference, held recently in Boston, industry and academic scientists [...]
